Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Stereotactic Radiosurgery
What rate of second malignancies do you quote for patients receiving radiosurgery for benign CNS tumors?
Answer from: Radiation Oncologist at Community Practice
<1% at 10 years based on following Lancet Oncology paper: https://www.ncbi.nlm.nih.gov/pubmed/30473468
Comments
Radiation Oncologist at Bismarck Cancer Center
Agree - timely question given recency of the publi...
Radiation Oncologist at Radiant Oncology
Thank you both for the references! At the core of ...
Radiation Oncologist at Bismarck Cancer Center
That's a good question, and I agree with your conc...
Radiation Oncologist at Bismarck Cancer Center
(apologies, cut off) I think your non-threshold l...
Radiation Oncologist at Bismarck Cancer Center
up to 1% at 10y and 1-2% at 20y is a pretty reason...
1275
1276
1277
1278
1279
Sign in or Register to read more
5029
Related Questions
What is the role of radiation in intra labyrinthine (cochlear) schwannoma?
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
Do you ever consider a third course of CNS radiation to the same area for an in-field recurrence?
Would you prefer SBRT or fractionated radiation for a sacral peripheral nerve sheath tumor?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
What is your approach for LINAC based radiosurgery when dealing with benign perioptic lesions very close to the optics apparatus?
How do you manage follow up for patient who was diagnosed with pineal gland germinomas with drop metastatic to the spinal cord?
How would you approach a patient with recurrent grade 3 oligodendroglioma (MGMT-methylated, IDH mutant, 1p/19q co-deleted) 1 year after gross total resection and adjuvant chemotherapy and radiation?
How would you manage an enlarging brain metastasis that has progressed in size three months after radiosurgery?
Agree - timely question given recency of the publi...
Thank you both for the references! At the core of ...
That's a good question, and I agree with your conc...
(apologies, cut off) I think your non-threshold l...
up to 1% at 10y and 1-2% at 20y is a pretty reason...